open access

Vol 12, Supp. B (2017)
Praca na konkurs pt. "Terapia skojarzona"
Published online: 2018-03-04
Get Citation

New diagnosed hypertension in a patient during anastrozole hormone therapy due to breast cancer

Joanna Ewelina Latek-Książek, Małgorzata Woźniak, Elżbieta Piechocka, Robert Julian Gil, Aneta Iwona Gziut
DOI: 10.5603/FC.2017.0045

open access

Vol 12, Supp. B (2017)
Praca na konkurs pt. "Terapia skojarzona"
Published online: 2018-03-04

Abstract

We present the case of 63-year-old patient with breast cancer treated with anastrozole, in whom the development
of arterial hypertension during chemotherapy occurred. The patient using an aromatase inhibitor for the oncological
treatment, did not experience the development of other diseases of the cardiovascular system besides elevated blood
pressure. After inclusion of five antihypertensive drugs normal blood pressure was achieved.

Abstract

We present the case of 63-year-old patient with breast cancer treated with anastrozole, in whom the development
of arterial hypertension during chemotherapy occurred. The patient using an aromatase inhibitor for the oncological
treatment, did not experience the development of other diseases of the cardiovascular system besides elevated blood
pressure. After inclusion of five antihypertensive drugs normal blood pressure was achieved.

Get Citation

Keywords

arterial hypertension, hormone therapy, breast cancer, dyslipidemia

About this article
Title

New diagnosed hypertension in a patient during anastrozole hormone therapy due to breast cancer

Journal

Folia Cardiologica

Issue

Vol 12, Supp. B (2017)

Pages

23-25

Published online

2018-03-04

DOI

10.5603/FC.2017.0045

Keywords

arterial hypertension
hormone therapy
breast cancer
dyslipidemia

Authors

Joanna Ewelina Latek-Książek
Małgorzata Woźniak
Elżbieta Piechocka
Robert Julian Gil
Aneta Iwona Gziut

References (4)
  1. Zamorano JL, Lancellotti P, Rodriguez-Muñoz D, et al. [2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines]. Kardiol Pol. 2016; 74(11): 1193–1233.
  2. Red Ty, Narkiewicz K, Gaciong Z, et al. Zasady postępowania w nadciśnieniu tętniczym — 2015. Nadciśnienie Tętnicze. 2015; 1(1): 1–70.
  3. Buzdar A, Howell A, Cuzick J, et al. Arimidex, Tamoxifen, Alone or in Combination Trialists' Group. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol. 2006; 7(8): 633–643.
  4. Wojtacki J, Lesniewski-Kmak K, Pawlak W, et al. Anastrozole therapy and lipid profile: an update. Eur J Cancer Suppl . 2004; 2(3): 142.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl